top of page
Precision Exosome Selection Revolutionary Diagnostics
Promising ExoMAIN data, 30 years of biosensor manufacturing experience combined with the current trend in AI could bring a new era in low cost early cancer screening
Learn More about ExoMain
Our Approach
Neautra Release Logo copy_2.png
exomain logo-3.png
Exosomes for Early Stage Cancer Diagnostics
​Exosomes are nanoparticles that are released and received by nearly all cells in the body. These highly-evolved vesicles act as one of our body’s communication systems, same for cancer cells, delivering important molecular payloads from cell to cell. 
Organs in the body2_3.png

*Light intensity represents future work

Winning Over Cancer Starts with Early Detection 

The exosome research field has exploded in the last decade, and SOL Bio Corp. has remained at the forefront of the field, developing a highly efficient cancer isolation protocol for liquid biopsy tests using exosomes
Our Team
bottom of page